University of California, School of Veterinary Medicine, Department of Medicine and Epidemiology, Davis, CA, 95616, USA.
University of Georgia, College of Veterinary Medicine, Department of Pathology, Athens, GA, 30602, USA.
Fish Shellfish Immunol. 2024 Feb;145:109368. doi: 10.1016/j.fsi.2024.109368. Epub 2024 Jan 9.
Veronaea botryosa is the etiological agent of a systemic phaeohyphomycosis known as "fluid belly" in white sturgeon (Acipenser transmontanus). Fluid belly is a critical disease affecting sturgeon aquaculture and the caviar industry for which there are no commercially available vaccines or approved antifungal treatments to manage outbreaks. The primary aim of this study was to investigate the effect of a V. botryosa [conidia], a V. botryosa [mold], and a Saccharomyces cerevisiae [yeast] formalin-killed vaccine on sturgeon immune responses to fungal challenge. Immunization consisted of an initial intracoelomic injection with one of the three treatment preparations, followed by a vaccine booster four weeks later by the same route and dose. Experimental challenge by intramuscular injection with a virulent V. botryosa conidia suspension followed after another four weeks. Non-challenged control fish received injections of PBS. The inactivated vaccines proved safe for white sturgeon fingerlings. Sturgeon immunized with either V. botryosa [mold] or S. cerevisiae [yeast] exhibited a significantly different pro-inflammatory response upon challenge with V. botryosa compared to non-immunized fish. Challenged fish developed clinical signs similar to those reported during natural outbreaks of fluid belly. Positive control treatments (those not immunized but challenged with V. botryosa) experienced the highest mortality; however, survival curves were similar amongst all treatments (p < 0.05). Furthermore, the S. cerevisiae [yeast] vaccine resulted in comparatively lower fungal persistence and fewer lesions following histological analysis. Further efforts evaluating the potential of Saccharomyces spp. as a vaccine candidate against fluid belly are warranted.
胶孢瓶霉是一种系统性暗色丝孢霉病的病原体,这种病在白鲟(Acipenser transmontanus)中被称为“腹水病”。腹水病是一种严重影响鲟鱼养殖业和鱼子酱产业的疾病,目前尚无商业上可用的疫苗或批准的抗真菌药物来控制疫情爆发。本研究的主要目的是研究胶孢瓶霉[分生孢子]、胶孢瓶霉[霉菌]和酿酒酵母[酵母]甲醛灭活疫苗对白鲟对真菌挑战的免疫反应的影响。免疫接种包括用三种治疗制剂中的一种进行初次腹腔内注射,然后在四周后通过相同的途径和剂量进行疫苗加强针。在四周后,通过肌肉内注射有毒的胶孢瓶霉分生孢子悬浮液进行实验性挑战。未受挑战的对照鱼接受 PBS 注射。灭活疫苗对白鲟鱼苗是安全的。与未免疫的鱼相比,用胶孢瓶霉[霉菌]或酿酒酵母[酵母]免疫的鲟鱼在受到胶孢瓶霉挑战时表现出明显不同的促炎反应。受挑战的鱼表现出类似于自然爆发腹水病时报告的临床症状。阳性对照处理(未免疫但用胶孢瓶霉挑战)的死亡率最高;然而,所有处理组的生存曲线相似(p<0.05)。此外,酿酒酵母[酵母]疫苗在组织学分析后导致真菌持续时间和病变较少。进一步评估酿酒酵母属作为腹水病疫苗候选物的潜力是值得的。